There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Opioid Treatment Surge Act

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To establish an annual fee applicable to opioid manufacturers.


Actions Overview (1)

Date Actions Overview
06/05/2019Introduced in House

All Actions (3)

Date All Actions
06/06/2019Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
06/05/2019Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
06/05/2019Introduced in House
Action By: House of Representatives

Cosponsors (0)

No cosponsors.


Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce06/05/2019 Referred to
House Energy and Commerce Subcommittee on Health06/06/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Subjects (5)


Latest Summary (1)

There is one summary for H.R.3105. View summaries

Shown Here:
Introduced in House (06/05/2019)

Opioid Treatment Surge Act

This bill requires the Department of Health and Human Services to assess market-share-based fees, for the next 10 years, on drug manufacturers that have produced opioid drugs since 1999. Opioid drugs manufactured to treat opioid addiction, cancer patients, or hospice patients are, however, exempt from this assessment. All assessed fees must be used for the substance abuse prevention and treatment block grant program.